AXA CEO The Impact of Obesity on Health Insurers

Поделиться
HTML-код
  • Опубликовано: 12 мар 2024
  • AXA CEO Thomas Buberl says we are at the beginning of a revolution in obesity treatment. He shares details on how drugs like Ozempic will positively impact health insurers. He speaks on 'The David Rubenstein Show: Peer-to-Peer Conversations." This interview was recorded January 30 in New York.

Комментарии • 2